WATWATERS CORP /DE/

NYSE waters.com


$ 350.87 $ 14.69 (4.37 %)    

Friday, 10-May-2024 15:59:58 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 351.11
$ 340.88
$ 0.00 x 0
$ 0.00 x 0
$ 340.88 - $ 352.04
$ 231.90 - $ 363.80
791,032
na
20.87B
$ 0.90
$ 34.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-30-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-02-2023 07-01-2023 10-Q
5 05-09-2023 04-01-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-03-2022 10-01-2022 10-Q
8 08-04-2022 07-02-2022 10-Q
9 05-05-2022 04-02-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 10-02-2021 10-Q
12 08-05-2021 07-03-2021 10-Q
13 05-06-2021 04-03-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 10-28-2020 09-26-2020 10-Q
16 07-29-2020 06-27-2020 10-Q
17 04-29-2020 03-28-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 10-30-2019 09-28-2019 10-Q
20 07-31-2019 06-29-2019 10-Q
21 05-03-2019 03-30-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-02-2018 09-29-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 07-01-2017 10-Q
29 05-05-2017 04-01-2017 10-Q
30 02-24-2017 12-31-2016 10-K
31 11-04-2016 10-01-2016 10-Q
32 08-05-2016 07-02-2016 10-Q
33 05-06-2016 04-02-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-06-2015 10-03-2015 10-Q
36 08-07-2015 07-04-2015 10-Q
37 05-08-2015 04-04-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 10-31-2014 09-27-2014 10-Q
40 08-01-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-underweight-on-waters-lowers-price-target-to-295

Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Underweight and lowers the price target from $300 to $295.

 td-cowen-maintains-hold-on-waters-raises-price-target-to-358

TD Cowen analyst Dan Brennan maintains Waters (NYSE:WAT) with a Hold and raises the price target from $350 to $358.

 stifel-maintains-hold-on-waters-raises-price-target-to-332

Stifel analyst Daniel Arias maintains Waters (NYSE:WAT) with a Hold and raises the price target from $330 to $332.

 baird-maintains-neutral-on-waters-lowers-price-target-to-312

Baird analyst Catherine Ramsey maintains Waters (NYSE:WAT) with a Neutral and lowers the price target from $319 to $312.

 laboratory-instruments-company-waters-corp-projects-steady-growth-amid-global-sales-fluctuations-details

Waters Corp (NYSE: WAT) reported Q1 2024 sales of $636.8 million, beating analyst consensus. Quarterly rev declined 7%. Adjuste...

 waters-corp-reiterated-fy24-revenue-growth-of-00-20-yoy-vs-298b-est-adj-eps-of-1175-1205-vs-1189-est

Full-Year 2024 Financial Guidance The Company continues to expect full-year 2024 organic constant currency sales growth to be ...

 waters-corp-expects-q2-sales-decline-of-65-45-vs-72884m-est-adj-eps-of-250-260-vs-277-est

Second Quarter 2024 Financial Guidance The Company expects second quarter 2024 organic constant currency sales growth to be in...

 waters-q1-2024-adj-eps-221-beats-210-estimate-sales-636839m-beat-635578m-estimate

Waters (NYSE:WAT) reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $2.10 by 5.24 per...

 waters-accelerates-the-development-of-gene-based-therapeutics-with-new-gtxresolve-premier-sec-columns

New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the developmen...

 waters-corporation-unveils-alliance-is-bio-hplc-system-to-help-biopharma-qc-labs-increase-efficiency-and-reduce-errors

New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost effic...

 evercore-isi-group-maintains-in-line-on-waters-raises-price-target-to-340

Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a In-Line and raises the price target from $320 to $...

 top-7-biotech-stock-winners-as-weight-loss-drug-battle-escalates-goldman-sachs-names-best-picks

Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand...

 waters-q4-earnings-beats-estimates-ceo-touts-strong-execution-in-tough-market-conditions

Waters Corporation beats Q4 earnings estimates, outlining mixed regional sales performance and cautious outlook for 2024.

 waters-q4-adj-eps-362-beats-355-estimate-sales-81947m-beat-81503m-estimate

Waters (NYSE:WAT) reported quarterly Adj. earnings of $3.62 per share which beat the analyst consensus estimate of $3.55 by 1.9...

 earnings-scheduled-for-february-6-2024

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION